Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BARX1 | hg38_v1_chr9_-_93955347_93955362 | 0.29 | 1.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_151025343 Show fit | 7.74 |
ENST00000521632.1
|
glutathione peroxidase 3 |
|
chr13_-_49413749 Show fit | 4.48 |
ENST00000610540.4
ENST00000347776.9 ENST00000409082.5 |
calcium binding protein 39 like |
|
chrX_-_15493234 Show fit | 4.45 |
ENST00000380420.10
|
pirin |
|
chr11_-_102530738 Show fit | 4.06 |
ENST00000260227.5
|
matrix metallopeptidase 7 |
|
chr5_+_40909490 Show fit | 3.64 |
ENST00000313164.10
|
complement C7 |
|
chr8_-_123737378 Show fit | 3.62 |
ENST00000419625.6
ENST00000262219.10 |
annexin A13 |
|
chr7_-_16881967 Show fit | 3.46 |
ENST00000402239.7
ENST00000310398.7 ENST00000414935.1 |
anterior gradient 3, protein disulphide isomerase family member |
|
chr14_-_67412112 Show fit | 3.29 |
ENST00000216446.9
|
pleckstrin 2 |
|
chr12_-_91178520 Show fit | 3.22 |
ENST00000425043.5
ENST00000420120.6 ENST00000441303.6 ENST00000456569.2 |
decorin |
|
chr9_-_92404690 Show fit | 3.18 |
ENST00000447356.1
|
osteoglycin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 9.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 8.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 7.6 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.3 | 5.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.3 | 5.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 5.1 | GO:0006936 | muscle contraction(GO:0006936) |
0.6 | 4.7 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.0 | 4.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.2 | 4.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 3.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 18.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 16.6 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 15.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 7.0 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 5.7 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 4.2 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 4.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 4.0 | GO:0005901 | caveola(GO:0005901) |
0.0 | 3.7 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 3.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 11.3 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 10.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 9.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 8.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 7.3 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 6.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 5.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 5.0 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 4.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 4.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 13.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 7.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 5.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 5.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 3.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 2.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 2.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 2.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 2.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 5.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 5.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 5.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 4.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 4.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 3.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 3.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 2.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |